How Long Do You Have to Take Allergy Shots? The Full Commitment

Stopping allergy shots after just one year is not recommended by AAAAI or ACAAI guidelines, even if you feel significantly better. The symptomatic improvement you experience during the first year reflects early desensitization — but the immune reprogramming required for lasting, post-treatment benefit requires a minimum of 3 years of maintenance dosing. Studies by Nouri-Aria et al. in JACI 2004 show that patients who stop before completing 3 years have significantly higher rates of symptom relapse compared to those who complete the full course. Durham et al.'s landmark NEJM 1999 study — which established post-treatment durability — used a 3-to-4-year protocol. If you stop at year one, you are very likely to need to restart. Discuss timing with your allergist before making any changes to your schedule.

Over a standard 3-year course, you can expect approximately 57 to 60 clinic visits. Over a 5-year course, the total reaches 80 to 100 visits. The distribution is heavily front-loaded: during the conventional build-up phase (8-28 weeks at 1-3 visits per week), you may complete 25 to 84 injections in the first 7 months alone. Once you reach maintenance, visit frequency drops to every 2 to 4 weeks — about 12 to 15 visits per year. Cluster protocols can reduce build-up visits by approximately 50%, reaching roughly the same maintenance dose in 4 to 8 weeks instead of 8 to 28 weeks, per Calabria in Annals of Allergy 2023.

Each allergy shot appointment requires a minimum of 30 to 45 minutes at the clinic: approximately 5 to 10 minutes for check-in and vitals, a few seconds for the actual injection, and a mandatory 30-minute post-injection observation period required by AAAAI and ACAAI guidelines. The observation period exists because approximately 85 percent of systemic reactions occur within 30 minutes of the injection, per Epstein et al. in Annals of Allergy 2011. If you add travel time and parking, the realistic time block per visit is 60 to 90 minutes. Over 57 visits in a 3-year course, that totals roughly 110 hours of patient time — a meaningful commitment to factor into your schedule.

Missing allergy shots requires dose adjustment, and the protocol depends on how long the gap was. During the build-up phase, a gap of less than 2 weeks typically allows normal progression; 2 to 3 weeks may require repeating the last dose; 3 to 5 weeks typically requires stepping back one or two doses; and a gap of 90 days or more usually means restarting from bottle one. During maintenance, gaps up to 5 weeks are generally tolerated; 5 to 11 weeks requires reducing the dose by 25 to 55 percent; and a gap of 3 to 4 months often requires restarting SCIT from the beginning. These empirical schedules come from the AAAAI Practice Parameter supplement and Larenas-Linnemann et al. in Annals of Allergy 2020.

The total cost of allergy shots over a 3-year course runs approximately $4,500 to $6,500 for patients with commercial insurance (primarily copays of $15 to $50 per visit) and $6,300 to $9,000 for self-pay patients. Over a 5-year course, total cost estimates range from $7,000 to $15,000 including escalating maintenance-phase visit costs. These figures cover allergen extract preparation and injection administration fees but may exclude the initial allergy testing workup. Hidden costs include lost wages from weekly appointments during build-up (typically 60 to 90 minutes per visit), travel and parking, and potential childcare. The American Academy of Allergy, Asthma and Immunology publishes general cost guidance for patients considering immunotherapy.

Allergy shots produce disease-modifying effects that persist after treatment ends — but the duration varies by individual and course length. Durham et al. in NEJM 1999 established that 3 to 4 years of grass pollen SCIT produced benefit lasting at least 3 years after discontinuation. Eng et al. in Allergy 2006 reported sustained benefit in a small cohort at 12 years post-treatment. However, symptom relapse rates of 10 to 25 percent within 3 years of stopping have been documented, particularly among patients who did not complete the full course. Five-year courses appear to provide longer-lasting post-treatment benefit than 3-year courses in some studies. Annual allergist monitoring for 2 to 3 years after stopping is generally recommended.

Evidence suggests that allergy shots may significantly reduce the risk of children with allergic rhinitis developing asthma — though the evidence comes primarily from open-label rather than blinded trials. The Preventive Allergy Treatment (PAT) study by Moller et al. in JACI 2002 randomized 205 children aged 6 to 14 to 3 years of grass or birch SCIT versus no treatment and found significantly fewer asthma symptoms in the treated group (OR 2.52). Jacobsen et al.'s 10-year follow-up in Allergy 2007 confirmed that 25 percent of SCIT-treated children developed asthma versus 45 percent of controls — a protective effect persisting 7 years after treatment ended. EAACI prevention guidelines support SCIT for pollen-allergic children with moderate-to-severe rhinitis who have been symptomatic for at least 2 years.